Chapter title |
Circulating Biomarkers in Heart Failure
|
---|---|
Chapter number | 140 |
Book title |
Heart Failure: From Research to Clinical Practice
|
Published in |
Advances in experimental medicine and biology, January 2018
|
DOI | 10.1007/5584_2017_140 |
Pubmed ID | |
Book ISBNs |
978-3-31-978279-9, 978-3-31-978280-5
|
Authors |
Alexander E. Berezin, Berezin, Alexander E. |
Abstract |
Biological markers have served for diagnosis, risk stratification and guided therapy of heart failure (HF). Our knowledge regarding abilities of biomarkers to relate to several pathways of HF pathogenesis and reflect clinical worsening or improvement in the disease is steadily expanding. Although there are numerous clinical guidelines, which clearly diagnosis, prevention and evidence-based treatment of HF, a strategy regarding exclusion of HF, as well as risk stratification of HF, nature evolution of disease is not well established and requires more development. The aim of the chapter is to discuss a role of biomarker-based approaches for more accurate diagnosis, in-depth risk stratification and individual targeting in treatment of patients with HF. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 29 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 5 | 17% |
Student > Bachelor | 4 | 14% |
Student > Master | 4 | 14% |
Student > Doctoral Student | 2 | 7% |
Student > Postgraduate | 2 | 7% |
Other | 4 | 14% |
Unknown | 8 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 28% |
Biochemistry, Genetics and Molecular Biology | 4 | 14% |
Neuroscience | 2 | 7% |
Physics and Astronomy | 1 | 3% |
Nursing and Health Professions | 1 | 3% |
Other | 5 | 17% |
Unknown | 8 | 28% |